Nosari AM - Search Results

1

Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.

Morra E, Cesana C, Klersy C, Barbarano L, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Miqueleiz S, Bernuzzi P, Nosari AM, Lazzarino M. Morra E, et al. Among authors: nosari am. Leukemia. 2004 Sep;18(9):1512-7. doi: 10.1038/sj.leu.2403442. Leukemia. 2004. PMID: 15322559

2

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E. Cesana C, et al. Among authors: nosari am. J Clin Oncol. 2002 Mar 15;20(6):1625-34. doi: 10.1200/JCO.2002.20.6.1625. J Clin Oncol. 2002. PMID: 11896113

3

Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules.

Cesana C, Nosari AM, Klersy C, Miqueleiz S, Rossi V, Ferrando P, Valentini M, Barbarano L, Morra E. Cesana C, et al. Among authors: nosari am. Haematologica. 2003 Sep;88(9):1022-8. Haematologica. 2003. PMID: 12969810

4

Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature.

Marbello L, Ricci F, Nosari AM, Turrini M, Nador G, Nichelatti M, Tedeschi A, Vismara E, Morra E. Marbello L, et al. Among authors: nosari am. Leuk Res. 2008 Aug;32(8):1221-7. doi: 10.1016/j.leukres.2008.01.004. Epub 2008 Mar 3. Leuk Res. 2008. PMID: 18313749 Review.

5

Prognostic value of circulating CD34+ cells in myelodysplastic syndromes.

Cesana C, Klersy C, Brando B, Nosari A, Scarpati B, Scampini L, Molteni A, Nador G, Santoleri L, Formenti M, Valentini M, Mazzone A, Morra E, Cairoli R. Cesana C, et al. Leuk Res. 2008 Nov;32(11):1715-23. doi: 10.1016/j.leukres.2008.03.028. Epub 2008 May 5. Leuk Res. 2008. PMID: 18456323

6

Flow cytometry vs cytomorphology for the detection of hematologic malignancy in body cavity fluids.

Cesana C, Klersy C, Scarpati B, Brando B, Volpato E, Bertani G, Faleri M, Nosari A, Cantoni S, Ferri U, Scampini L, Barba C, Lando G, Morra E, Cairoli R. Cesana C, et al. Leuk Res. 2010 Aug;34(8):1027-34. doi: 10.1016/j.leukres.2010.02.008. Epub 2010 Mar 5. Leuk Res. 2010. PMID: 20206995

7

Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators.

Morra E, Gargantini L, Nosari A, Barbarano L, Pungolino E, Santoleri L, Bernuzzi P. Morra E, et al. Crit Rev Oncol Hematol. 2000 Aug;35(2):95-100. doi: 10.1016/s1040-8428(00)00065-2. Crit Rev Oncol Hematol. 2000. PMID: 10936466

8

Radiofrequency ablation of hepatic Hodgkin lymphoma.

Rusconi C, Rampoldi AG, Ravelli E, Nosari AM, Zilioli VR, Vanzulli A, Morra E. Rusconi C, et al. Among authors: nosari am. Leuk Lymphoma. 2009 Jan;50(1):141-4. doi: 10.1080/10428190802524837. Leuk Lymphoma. 2009. PMID: 19152173 No abstract available.

9

Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.

Cairoli R, Grillo G, Tedeschi A, Gargantini L, Marenco P, Tresoldi E, Barbarano L, Nosari AM, Morra E. Cairoli R, et al. Among authors: nosari am. Bone Marrow Transplant. 2002 Mar;29(6):473-7. doi: 10.1038/sj.bmt.1703401. Bone Marrow Transplant. 2002. PMID: 11960265

10

Infectious complications in chronic lymphocytic leukaemia.

Morra E, Nosari A, Montillo M. Morra E, et al. Hematol Cell Ther. 1999 Aug;41(4):145-51. doi: 10.1007/s00282-999-0145-0. Hematol Cell Ther. 1999. PMID: 10543369 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page